Differential signalling of both wild-type and Thr(343)Arg dopamine D(2short) receptor by partial agonists in a G-protein-dependent manner (Q43733620)

26 November 2017

title

Differential signalling of both wild-type and Thr(343)Arg dopamine D(2short) receptor by partial agonists in a G-protein-dependent manner (English)

1 reference

26 November 2017

0 references

Pauwels PJ

1

1 reference

26 November 2017

Tardif S

series ordinal

2

1 reference

26 November 2017

Colpaert FC

series ordinal

3

1 reference

26 November 2017

language of work or name

English

0 references

publication date

1 September 2001

1 reference

26 November 2017

published in

Biochemical Pharmacology

1 reference

26 November 2017

volume

62

1 reference

26 November 2017

issue

6

1 reference

26 November 2017

page(s)

723-732

1 reference

G protein-coupled receptors. II. Mechanism of agonist activation

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900717-1

Inverse agonism and neutral antagonism at alpha(1a)- and alpha(1b)-adrenergic receptor subtypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900717-1

Site-directed mutations in the third intracellular loop of the serotonin 5-HT(1A) receptor alter G protein coupling from G(i) to G(s) in a ligand-dependent manner

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900717-1

Evidence that antipsychotic drugs are inverse agonists at D2 dopamine receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900717-1

Novel (R)-2-amino-5-fluorotetralins: dopaminergic antagonists and inverse agonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900717-1

Derivatives of (R)-2-amino-5-methoxytetralin: antagonists and inverse agonists at the dopamine D2A receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900717-1

Basal signaling activity of human dopamine D2L receptor demonstrated with an ecdysone-inducible mammalian expression system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900717-1

Substitution of three amino acids switches receptor specificity of Gq alpha to that of Gi alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900717-1

Characterization of G-protein alpha subunits in the Gq class: expression in murine tissues and in stromal and hematopoietic cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900717-1

Ligand-receptor interactions as controlled by wild-type and mutant Thr(370)Lys alpha2B-adrenoceptor-Galpha15 fusion proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900717-1

Partial to complete antagonism by putative antagonists at the wild-type alpha(2C)-adrenoceptor based on kinetic analyses of agonist:antagonist interactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900717-1

Modulation of 5-HT1A receptor signalling by point-mutation of cysteine351 in the rat Galpha(o) protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900717-1

How efficacious are 5-HT1B/D receptor ligands: an answer from GTP gamma S binding studies with stably transfected C6-glial cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900717-1

Pharmacology of cloned human 5-HT1D receptor-mediated functional responses in stably transfected rat C6-glial cell lines: further evidence differentiating human 5-HT1D and 5-HT1B receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900717-1

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900717-1

Structural instability of a constitutively active G protein-coupled receptor. Agonist-independent activation due to conformational flexibility

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900717-1

Inverse agonism at heptahelical receptors: concept, experimental approach and therapeutic potential

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900717-1

Identification of a receptor/G-protein contact site critical for signaling specificity and G-protein activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900717-1

Hydrophobicity of residue351 of the G protein Gi1 alpha determines the extent of activation by the alpha 2A-adrenoceptor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900717-1

Modulation of 5-HT(1A) receptor activation by its interaction with wild-type and mutant g(alphai3) proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900717-1

The N-terminal extension of Galphaq is critical for constraining the selectivity of receptor coupling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900717-1

Functional characterization of a series of mutant G protein alphaq subunits displaying promiscuous receptor coupling properties

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900717-1

Site-directed mutagenesis of the human dopamine D2 receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900717-1

Heterogeneous ligand-mediated Ca(++) responses at wt and mutant alpha(2A)-adrenoceptors suggest multiple ligand activation binding sites at the alpha(2A)-adrenoceptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900717-1

Binding, gating, affinity and efficacy: the interpretation of structure-activity relationships for agonists and of the effects of mutating receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900717-1

Activating mutations of the serotonin 5-HT2C receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900717-1

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0006-2952(01)00717-1

1 reference

26 November 2017

1 reference